Takaichi Shimozato

This inventor holds 10 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Sankyo Company, Limited, Daiichi Sankyo Company, Limited, The University of Tokyo. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaichi Shimozato. Retrieved from https://idiyas.com/inventor/takaichi-shimozato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 20.0

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Kanagawa, JP (2010)
Miura-shi, JP (2011)
Miura, JP (2004 - 2012)
Tokyo, JP (2021 - 2023)

Company Filing History:

6 out of 613

Sankyo Company, Limited

patents

4 out of 462

Daiichi Sankyo Company, Limited

patents

2 out of 1,356

The University of Tokyo

patents

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11578138 - Anti-human TLR7 antibody (2023-02-14),

2. 11091560 - Anti-human TLR7 antibody (2021-08-17),

3. 8101650 - Method for treating a immunology-related disease (2012-01-24),

4. 8067396 - Amino alcohol compounds or phosphonic acid derivatives thereof (2011-11-29),

5. 7910617 - Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound (2011-03-22),

6. 7687491 - Heterocyclic compound (2010-03-30),

7. 7638551 - Amino alcohol compounds or phosphonic acid derivatives thereof (2009-12-29),

8. 7199150 - Amino alcohol compounds (2007-04-03),

9. 6964976 - Amino alcohol derivatives (2005-11-15),

10. 6723745 - Amino alcohol derivatives (2004-04-20),

Title: Takaichi Shimozato: Innovator in Pharmaceutical Antibodies

Introduction

Takaichi Shimozato is a prominent inventor based in Miura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibodies. With a total of 10 patents to his name, Shimozato's work has had a considerable impact on medical science.

Latest Patents

One of Shimozato's latest inventions is an anti-human TLR7 antibody. This pharmaceutical composition comprises an antibody that specifically binds to human TLR7 or monkey TLR7, while not binding to mouse TLR7 or rat TLR7. The invention is designed to inhibit the function of human TLR7 or monkey TLR7, showcasing its potential therapeutic applications.

Career Highlights

Throughout his career, Takaichi Shimozato has worked with notable companies in the pharmaceutical industry, including Sankyo Company, Limited and Daiichi Sankyo Company, Limited. His experience in these organizations has contributed to his expertise in antibody development and innovation.

Collaborations

Shimozato has collaborated with several professionals in his field, including Takahide Nishi and Futoshi Nara. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Takaichi Shimozato is a distinguished inventor whose work in pharmaceutical antibodies has paved the way for advancements in medical treatments. His contributions continue to influence the field and inspire future innovations.

Profile summary based on public USPTO records.